Related Experiment Video

Updated: Jun 24, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

[Risk factors in atherosclerotic coronary heart disease]

Danielle Hof1, Arnold von Eckardstein

  • 1Institut für Klinische Chemie, UniversitätsSpital, Zürich.

Therapeutische Umschau. Revue Therapeutique
|April 10, 2009
PubMed

Insights

Coronary heart disease (CHD) prevention is crucial globally. This review explores new biomarkers to improve risk assessment beyond traditional factors for better cardiovascular event prediction.

Area of Science:

  • Cardiology and Atherosclerosis Research
  • Biomarker Discovery and Validation
  • Public Health and Preventative Medicine

Context:

  • Coronary heart disease (CHD), driven by atherosclerosis, is a leading global cause of mortality.
  • Existing risk scores for 10-year cardiovascular events, while useful, exhibit limitations in sensitivity and positive predictive value.
  • There is a critical need for enhanced risk stratification strategies in CHD prevention.

Purpose:

  • To review the pathogenesis of coronary heart disease.
  • To examine current risk stratification methods for CHD.
  • To provide an overview of novel biomarkers for improved CHD risk assessment and prevention.

Summary:

  • This review details the mechanisms underlying coronary heart disease (CHD) and discusses established risk stratification tools.
  • It highlights the limitations of current clinical methods in accurately predicting cardiovascular events.
  • The focus is on emerging biomarkers and their potential applications in enhancing the prevention of CHD.

Impact:

  • Improved identification of individuals at high risk for coronary heart disease.
  • Potential for more personalized and effective preventative strategies against cardiovascular disease.
  • Advancement of clinical practice through the integration of novel biomarkers in risk assessment.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...